CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
CERE
Delisted
CERE was delisted on the 31st of July, 2024.
119 hedge funds and large institutions have $3.3B invested in Cerevel Therapeutics Holdings, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 41 increasing their positions, 39 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
22% less capital invested
Capital invested by funds: $4.23B → $3.3B (-$924M)
29% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 21
Holders
119
Holding in Top 10
3
Calls
$17.8M
Puts
$18.7M
Top Buyers
| 1 | +$46.8M | |
| 2 | +$13.6M | |
| 3 | +$12.4M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$10.3M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$9.16M |
Top Sellers
| 1 | -$27.7M | |
| 2 | -$23.1M | |
| 3 | -$10.3M | |
| 4 |
Morgan Stanley
New York
|
-$9.71M |
| 5 |
Alkeon Capital Management
New York
|
-$9.62M |